Kyle Piskel - Nov 16, 2023 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Principal Accounting Officer
Signature
/s/ Kyle Piskel by Stacy Taylor, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Nov 16, 2023
Transactions value $
-$1,070
Form type
4
Date filed
11/20/2023, 05:30 PM
Previous filing
Mar 8, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Sale -$1.07K -259 -0.3% $4.13 87.3K Nov 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade.